Showing results (91-100 of 203) with videos related to

Sort By:
Pageof 21
Biometrical Journal. Biometrische Zeitschrift|February 22, 2021
Correcting the bias of the net benefit estimator due to right-censored observationsJulien Péron, Maryam Idlhaj, Delphine Maucort-Boulch, et al.
Journal of Clinical Epidemiology|March 28, 2021
The Net Benefit of a treatment should take the correlation between benefits and harms into accountMarc Buyse, Everardo D Saad, Julien Peron, et al.
Contemporary Clinical Trials|April 18, 2021
Impact of follow-up on generalized pairwise comparisons for estimating the irinotecan benefit in advanced/metastatic gastric cancerAli N Chamseddine, Koji Oba, Marc Buyse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Using the expected survival to explain differences between the results of randomized trials: a case in advanced ovarian cancerMarc Buyse, Tomasz Burzykowski, Mahesh Parmar, et al.
Statistics in Medicine|January 4, 2023
Individualized Net Benefit estimation and meta-analysis using generalized pairwise comparisons in N-of-1 trialsJoris Giai, Julien Péron, Matthieu Roustit, et al.
Archives of Surgery (Chicago, Ill. : 1960)|July 20, 2007
Stents for palliation of obstructive metastatic colon cancer: impact on management and chemotherapy administrationMehdi Karoui, Antoine Charachon, Catherine Delbaldo, et al.
Orphanet Journal of Rare Diseases|October 12, 2023
Generalized pairwise comparisons of prioritized outcomes are a powerful and patient-centric analysis of multi-domain scoresVaiva Deltuvaite-Thomas, Mickaël De Backer, Samantha Parker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
Biological processes associated with breast cancer clinical outcome depend on the molecular subtypesChristine Desmedt, Benjamin Haibe-Kains, Pratyaksha Wirapati, et al.
Pageof 21